We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 71 results
  1. Imaging glial activation in patients with post-treatment Lyme disease symptoms: a pilot study using [11C]DPA-713 PET

    The pathophysiology of post-treatment Lyme disease syndrome (PTLDS) may be linked to overactive immunity including aberrant activity of the brain’s...

    Jennifer M. Coughlin, Ting Yang, ... Martin G. Pomper in Journal of Neuroinflammation
    Article Open access 19 December 2018
  2. Molecular Imaging of Neuroinflammation in Alzheimer’s Disease and Mild Cognitive Impairment

    Alzheimer’s disease (AD) is the most prevalent neurocognitive disorder. Due to the ineffectiveness of treatments targeting the amyloid cascade,...
    Chapter 2023
  3. Differences in neuroinflammation in people who started antiretroviral treatment during primary versus chronic HIV infection: an 18kDa Translocator protein (TSPO) positron emission tomography (PET) study

    Persistent inflammation is described in people with HIV (PWH) on antiretroviral treatment (ART). Early ART initiation is associated with reduced...

    Jasmini Alagaratnam, John P. Thornhill, ... Alan Winston in Journal of NeuroVirology
    Article Open access 04 April 2024
  4. TSPO PET Imaging as a Biomarker of Neuroinflammation in Neurodegenerative Disorders

    Neuroinflammation is a hallmark feature across the spectrum of neurodegenerative disorders. Central to neuroinflammation is the activation of...
    Eryn L. Werry, Fiona M. Bright, Michael Kassiou in Neurodegenerative Diseases Biomarkers
    Protocol 2022
  5. The mitochondrial protein TSPO in Alzheimer’s disease: relation to the severity of AD pathology and the neuroinflammatory environment

    The 18kD translocator protein (TSPO) is used as a positron emission tomography (PET) target to quantify neuroinflammation in patients. In Alzheimer’s...

    Emma F. Garland, Oliver Dennett, ... Delphine Boche in Journal of Neuroinflammation
    Article Open access 14 August 2023
  6. Osteopontin/secreted phosphoprotein-1 behaves as a molecular brake regulating the neuroinflammatory response to chronic viral infection

    Background

    Osteopontin (OPN) as a secreted signaling protein is dramatically induced in response to cellular injury and neurodegeneration. Microglial...

    Farina J. Mahmud, Yong Du, ... Amanda M. Brown in Journal of Neuroinflammation
    Article Open access 17 September 2020
  7. Translational Characterization of the Glia Role in Multiple Sclerosis

    Glial cells are important players in the pathogenesis of multiple sclerosis (MS)-induced injury to the central nervous system. Characterization of...
    Dumitru Ciolac, Stanislav A. Groppa, Gabriel Gonzalez-Escamilla in Translational Methods for Multiple Sclerosis Research
    Protocol 2021
  8. The Low-Affinity Binding of Second Generation Radiotracers Targeting TSPO is Associated with a Unique Allosteric Binding Site

    [ 11 C]-PK11195 (PK11195) has been widely used with positron emission tomography (PET) to assess levels of the translocator protein 18 kDa (TSPO) as a...

    Camilo Rojas, Marigo Stathis, ... Barbara S. Slusher in Journal of Neuroimmune Pharmacology
    Article 05 September 2017
  9. Positron Emission Tomography in Drug Development

    Central nervous system (CNS) drug development poses some unique challenges for drug developers in terms of drug delivery, assessment of target...
    Frans van den Berg, Eugenii A. (Ilan) Rabiner in Modern CNS Drug Discovery
    Chapter 2021
  10. Dissemination of brain inflammation in traumatic brain injury

    Traumatic brain injury (TBI) is recognized as a global health problem due to its increasing occurrence, challenging treatment, and persistent impacts...

    Kaibin Shi, Jianning Zhang, ... Fu-Dong Shi in Cellular & Molecular Immunology
    Article 07 March 2019
  11. Glia-Neuron Communication: Not a One-Way Street

    Obesity and its comorbidities are increasing at an alarming rate worldwide. A key mechanism in the development of this disease involves dysregulation...
    Andy Tran, Jim T. C. Chen, Denise D. Belsham in Glial-Neuronal Signaling in Neuroendocrine Systems
    Chapter 2021
  12. Bidirectional Associations among Nicotine and Tobacco Smoke, NeuroHIV, and Antiretroviral Therapy

    People living with HIV (PLWH) in the antiretroviral therapy (ART) era may lose more life-years to tobacco use than to HIV. Yet, smoking rates are...

    Shivesh Ghura, Robert Gross, ... Rebecca L. Ashare in Journal of Neuroimmune Pharmacology
    Article 13 December 2019
  13. Maternal Immune Activation as a Risk Factor for Schizophrenia: Evidence From Preclinical and Clinical Studies

    Maternal immune activation (MIA) has been implicated as a risk factor for schizophrenia by several epidemiological studies. Animal models have...
    Camila Nayane de Carvalho Lima, Tejaswini Doifode, ... Tatiana Barichello in Perinatal Inflammation and Adult Psychopathology
    Chapter 2020
  14. Independent and Combined Effects of Nicotine or Chronic Tobacco Smoking and HIV on the Brain: A Review of Preclinical and Clinical Studies

    Tobacco smoking is highly prevalent among HIV-infected individuals. Chronic smokers with HIV showed greater cognitive deficits and impulsivity, and...

    Linda Chang, Huajun Liang, ... Johnny J. He in Journal of Neuroimmune Pharmacology
    Article 27 October 2020
  15. Microstructural brain abnormalities in HIV+ individuals with or without chronic marijuana use

    Objective

    Cognitive deficits and microstructural brain abnormalities are well documented in HIV-positive individuals (HIV+). This study evaluated...

    Hannah A. Wang, Hua-Jun Liang, ... Linda Chang in Journal of Neuroinflammation
    Article Open access 06 August 2020
  16. Neurocognitive Complications of HIV Infection in Women: Insights from the WIHS Cohort

    Although sex differences in brain function and brain disorders are well documented, very few studies have had adequate number of women to address...
    Leah H. Rubin, Pauline M. Maki in Neurocognitive Complications of HIV-Infection
    Chapter 2019
  17. Escalating morphine dosing in HIV-1 Tat transgenic mice with sustained Tat exposure reveals an allostatic shift in neuroinflammatory regulation accompanied by increased neuroprotective non-endocannabinoid lipid signaling molecules and amino acids

    Background

    Human immunodeficiency virus type-1 (HIV-1) and opiates cause long-term inflammatory insult to the central nervous system (CNS) and worsen...

    Douglas J. Hermes, Ian R. Jacobs, ... Sylvia Fitting in Journal of Neuroinflammation
    Article Open access 18 November 2020
  18. Cytokines, Oxidative Stress and Cellular Markers of Inflammation in Schizophrenia

    In this article, we review current evidence linking immune dysfunction in schizophrenia and related psychotic disorders focusing particularly on...
    Rachel Upthegrove, Golam M. Khandaker in Neuroinflammation and Schizophrenia
    Chapter 2019
  19. The application of positron emission tomography (PET) imaging in CNS drug development

    As drug discovery and development in Neuroscience push beyond symptom management to disease modification, neuroimaging becomes a key area of...

    Ivonne Suridjan, Robert A. Comley, Eugenii A Rabiner in Brain Imaging and Behavior
    Article 27 September 2018
Did you find what you were looking for? Share feedback.